Literature DB >> 15756908

Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.

Dante D Cáceres1, Jeannette Iturrieta, Cristian Acevedo, Christian Huidobro, Nelson Varela, Luis Quiñones.   

Abstract

BACKGROUND: Prostate cancer (PCa) is one of the most common male cancers, but the burden of this disease shows remarkable worldwide variation. The role of susceptibility low penetrance genes and environmental factors in the etiology of (PCa) is unclear, but may involve, in some cases, multiple alleles at multiple loci and environmental factors. STUDY
OBJECTIVES: To assess whether CYP1A1, GSTM1, GSTT1 susceptibility genotypes, smoking status and alcohol consumption factors contribute to PCa risk, gene-gene and gene-environment interactions were analyzed. DESIGN AND PARTICIPANTS: We explored interactions on a multiplicative scale conducting a population-based case-control and a case-only study on 103 incident PCa patients and 132 unrelated controls. MAIN
RESULTS: The interaction odds ratios (IOR) for PCa risk were increased in men who had both susceptibility genotypes GST (M1; T1) null and CYP1A1-M1* in a case-control and case-only design (IOR(cc): 1.11; 95% CI: 0.12-10.02; IOR(cc): 6.23; 95%, CI: 0.51-75.89; IOR(co): 2.80; 95% CI: 0.44-17.45 and IORco: 2.65; 95%, CI: 0.30-25.40). No clear evidence for interaction on a multiplicative scale between smoking status, alcohol consumption and genetic polymorphisms in PCa risk was observed.
CONCLUSIONS: Our findings suggest that the interaction between genetic polymorphisms in GST (T1; M1) and CYP1A1-M1* would play a significant role as a modifying factor on PCa risk in Chilean people. However, these preliminary exploratory results should be confirmed in a larger study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756908     DOI: 10.1007/s10654-004-1632-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  60 in total

1.  Metabolic gene allele nomenclature.

Authors:  S Garte; P Boffetta; N Caporaso; P Vineis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-12       Impact factor: 4.254

Review 2.  Gene-environment interrelations in prostate cancer.

Authors:  R B Hayes
Journal:  Epidemiol Rev       Date:  2001       Impact factor: 6.222

3.  Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer.

Authors:  Sholom Wacholder; Nathaniel Rothman; Neil Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-06       Impact factor: 4.254

4.  Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.

Authors:  S G Carmella; A Borukhova; S A Akerkar; S S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-02       Impact factor: 4.254

5.  Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.

Authors:  T Shimada; C H Yun; H Yamazaki; J C Gautier; P H Beaune; F P Guengerich
Journal:  Mol Pharmacol       Date:  1992-05       Impact factor: 4.436

6.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Authors:  J Seidegård; W R Vorachek; R W Pero; W R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking.

Authors:  S N Kelada; S L Kardia; A H Walker; A J Wein; S B Malkowicz; T R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-12       Impact factor: 4.254

8.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism.

Authors:  S Pemble; K R Schroeder; S R Spencer; D J Meyer; E Hallier; H M Bolt; B Ketterer; J B Taylor
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

Review 9.  Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.

Authors:  H Raunio; K Husgafvel-Pursiainen; S Anttila; E Hietanen; A Hirvonen; O Pelkonen
Journal:  Gene       Date:  1995-06-14       Impact factor: 3.688

Review 10.  The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer.

Authors:  Paolo Vineis
Journal:  Toxicology       Date:  2002-12-27       Impact factor: 4.221

View more
  17 in total

1.  RETRACTED: Relationship Between Aldosterone Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk.

Authors:  Chao Ou; Yan Zhao; Jiang-Hua Liu; Bo Zhu; Pei-Zhang Li; Hui-Liu Zhao
Journal:  Technol Cancer Res Treat       Date:  2016-06-22

Review 2.  Association between glutathione S-transferases M1 and T1 gene polymorphisms and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Qiliang Cai; Zhun Wang; Wei Zhang; Xuemei Guo; Zhiqun Shang; Ning Jiang; Jing Tian; Yuanjie Niu
Journal:  Tumour Biol       Date:  2013-07-26

Review 3.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

4.  Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy.

Authors:  J Cotignola; D B Leonardi; A Shahabi; A D Acuña; M C Stern; N Navone; C Scorticati; A De Siervi; O Mazza; E Vazquez
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-11-13       Impact factor: 5.554

5.  Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?

Authors:  Zahra Ousati Ashtiani; Sayed-Mohammad Hasheminasab; Mohsen Ayati; Bareto Sabah Goulian; Mohammad Hossein Modarressi
Journal:  Pathol Oncol Res       Date:  2010-11-19       Impact factor: 3.201

6.  Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.

Authors:  Guangye Han; Yanjuan Ma; Pei Liu; Xiaoxia Wei; Xinjun Zhang; Feng Zhu
Journal:  Tumour Biol       Date:  2013-02-06

7.  Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis.

Authors:  Jihong Wang; Yuemin Xu; Qiang Fu; Jianjun Yu; Zhong Chen; Zhangshun Liu; Chao Li; Hui Guo; Mingkai Xie
Journal:  Tumour Biol       Date:  2013-03-02

8.  Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis.

Authors:  Huawen Li; Deqian Xiao; Liren Hu; Taiping He
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

9.  CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.

Authors:  Gang Ding; Weiguo Xu; Hedai Liu; Ming Zhang; Qian Huang; Zhijun Liao
Journal:  Mol Biol Rep       Date:  2013-03-09       Impact factor: 2.316

10.  Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals.

Authors:  Karina Cordero; Iris Espinoza; Dante Caceres; Angela Roco; Carla Miranda; Valentina Squicciarini; Paula Santander; Kuen Lee; Iván Saavedra; Luis Quiñones
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.